Results 101 to 110 of about 1,066 (137)
Some of the next articles are maybe not open access.

Abstract CT504: A phase 1 clinical trial to evaluate safety, tolerability, pharmacokinetics (PK) and efficacy of D-1553, a novel KRASG12C inhibitor, in patients with advanced or metastatic solid tumor harboring KRASG12C mutation

Cancer Research, 2022
Background: KRASG12C mutation is an oncogenic driver that occurs in approximately 15% of non-small cell lung cancer (NSCLC), 3% of colorectal cancer (CRC), and ~1% of several other solid tumors.
Timothy Price   +18 more
semanticscholar   +1 more source

Abstract 6305: Downregulation of glutamine transporter stably and significantly attenuates weight loss by a cachexia-inducing pancreatic cancer xenograft

Cancer Research, 2022
Cancer-induced cachexia is commonly observed in pancreatic cancer. The syndrome induces significant weight loss and leads to morbidity, intolerance to chemotherapy, and mortality.
B. Krishnamachary   +11 more
semanticscholar   +1 more source

Abstract 916: Dec2, a circadian rhythm gene is necessary for disseminated tumor cell survival in a novel murine model of pancreatic cancer dormancy

Cancer Research, 2022
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a proclivity for early metastasis. Resection remains the only chance for long term survival though most patients die from metastatic recurrence. While most patients recur within
A. Casabianca   +3 more
semanticscholar   +1 more source

Abstract CT197: Phase Ib study of LXH254 + trametinib (TMT) in patients (pts) with NRAS-mutant melanoma

Cancer Research, 2022
Background: MAPK pathway dysregulation is a characteristic molecular abnormality of melanoma. NRAS mutations in melanoma lead to constitutive MAPK activation and subsequent MEK and ERK activation.
F. de Braud   +26 more
semanticscholar   +1 more source

Abstract 3154: Assessing hematopoietic stem cell fitness within a nanobioreactor in microgravity

Cancer Research, 2022
Microgravity coupled with increased radiation exposure aboard the ISS provides a unique environment to simulate and study response to injury, inflammatory signaling, aging, and (pre-)malignant transformation of normal human hematopoietic stem cells ...
Luisa Ladel   +4 more
semanticscholar   +1 more source

Abstract 3414: Systematic comparison of ctDNA vs tissue sequencing with a large panel to guide therapy in patients with advanced cancer: A study from the French National Center for Precision Medicine (PRISM)

Cancer Research, 2022
Background: Genomic profiling with tissue sequencing is still considered as the gold standard despite several limitations including screening failures due to limited tissue availability, and inability to capture intratumor spatial and temporal ...
A. Bayle   +19 more
semanticscholar   +1 more source

Fully Remote Software Development as a New Standard in the IT Industry: European Study 2022—2023

PROGRAMMNAYA INGENERIA, 2023
The pandemic and the emergence of the COVID-economy continue to have a significant impact on the organization of labor in the industries of the "new economy", of which the information technology industry is a prominent representative.
D. Pashchenko
semanticscholar   +1 more source

BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic solid tumor: Results from a first-in-human phase 1 study.

Journal of Clinical Oncology, 2023
3001 Background: BL-B01D1 is a first-in-class novel ADC consisting of an EGFRxHER3 bispecific antibody linked to a novel TOP-I inhibitor payload via a cleavable linker. We now present safety/efficacy results from a FIH phase I study of BL-B01D1. Methods:
Li Zhang   +18 more
semanticscholar   +1 more source

Comparison of Maternal and Perinatal Outcome Between 4 cm vs 6 cm Cervical    Dilatation at Amniotomy

Pakistan Armed Forces Medical Journal
Objective: To compare maternal and perinatal outcome between 4 cm vs 6 cm cervical dilatation at Amniotomy among women undergoing induction of labor at our unit. Study Design: Comparative cross-sectional study.
Seema Tariq, T. Yazdani
semanticscholar   +1 more source

Abstract P1-03-01: Towards Universal Germline Screening for Breast Cancer, Planning for a Sustainable Future: A Single-Center Retrospective Analysis

Clinical Cancer Research
Background: The implementation of germline genetic testing is complex due to emerging therapeutic indications such as adjuvant Olaparib for BRCA-mutated breast cancer (BC).
Adela Rodriguez Hernandez Barbara Adamo   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy